KUALA LUMPUR, April 26 (Bernama) -- Claritas HealthTech Pte Ltd (Claritas), a healthcare technology company has announced finalising a licence agreement to commercialise the Paediatric MRI software developed and patented by the University of North Carolina (UNC) at Chapel Hill.
This licence agreement grants Claritas the exclusive worldwide right to promote and market the deep-learning software solution that improves the quality and efficiency of paediatric MRI scans through Retrospective Artifact Correction.
“MRI scans are particularly sensitive to physical movement and for a child to remain motionless for up to an hour to obtain an image of appropriate quality is difficult. The thought of spending 45 minutes to an hour in a noisy, enclosed tube can be intimidating for adults. Sometimes, a child may have to take sedation or undergo a general anaesthetic which brings additional risk and requires close supervision.
“This can add delay and limit the use of a valuable tool,” commented Dr Arup Paul, Chief Clinical Strategy Officer, at Claritas HealthTech in a statement.
“We are excited about this new technology that can ‘correct’ the image impairment (artifact) caused by physical movement that previously rendered MRI images unusable or difficult to read.
“This will reduce the need to repeat scans, give clinicians more confidence in interpreting these images and determining clinical management. This step change in 'artifact correction' will help drive access, quality and safety in Paediatric care, benefiting patients and those who care for them.”
Claritas aims to transform the diagnostics industry with powerful and effective software products created using image enhancement and AI technology enabling and assisting doctors and physicians to make accurate diagnosis and improve patient lives.
For more information, visit www.claritashealthtech.com.
-- BERNAMA
No comments:
Post a Comment